कोशिश गोल्ड - मुक्त

Role of global pharma industry in TB diagnostics - II

Chronicle Pharmabiz

|

August 21, 2025

IN the first part of this article, the authors described the TB remains a persistent global health challenge, particularly in lowand middle-income countries, and the global pharma industry has been at the forefront of TB diagnostics. In this concluding part, they are discussing about traditional sample transportation methods, DBS and dried sputum technologies, advanced molecular transport media & impact on TB diagnostics and public health.

- Pratap N Mukhopadhyaya, Krishna H Goyani & Daisy Patel

Traditional sample transportation methods

Historically, TB sample transportation has relied heavily on conventional methods, such as cold chain systems, where samples are kept refrigerated or frozen during transit. This method is effective in preserving the viability of samples, particularly for sputum and other biological materials that are prone to degradation at room temperature. However, maintaining a cold chain can be challenging, especially in remote or resource-limited areas where access to electricity and reliable refrigeration is limited.

Strengths

Preserves sample integrity: Cold chain systems are effective in maintaining the viability of TB samples, which is crucial for accurate diagnostic results.

Widely adopted: Cold chain logistics are well-established and commonly used across various medical and research fields, making them a standard practice in TB sample transportation.

Limitations

Logistical challenges: Maintaining a cold chain requires reliable infrastructure, including continuous power supply and proper storage facilities, which may not be available in remote areas.

High costs: The need for refrigeration, specialized packaging, and temperature monitoring increases the overall cost of transportation, making it less feasible for widespread use in low-income regions.

Limited reach: Cold chain-dependent solutions are less accessible in regions with poor infrastructure, limiting their effectiveness in those areas most affected by TB.

DBS and dried sputum technologies

To address the challenges of cold chain logistics, alternative methods such as Dried Blood Spot (DBS) and dried sputum technologies have been developed. These methods involve collecting samples on specially treated paper, which allows them to be dried and stored at room temperature for extended periods.

Chronicle Pharmabiz से और कहानियाँ

Chronicle Pharmabiz

Chronicle Pharmabiz

Home-grown CAR-T cell therapies gaining ground

INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.

time to read

4 mins

November 27, 2025

Chronicle Pharmabiz

NPPA extends price fixation on orthopaedic implants for 1 year

IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

FICCI envisages it's Smart AAMs to boost healthcare

In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

DoP asked to bring policy for affordable drug pricing

THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Ramaiah emphasises need for bone health and osteoporosis diagnosis

RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Nathealth calls for action in 2026-27 Union Budget

NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.

time to read

1 mins

November 27, 2025

Chronicle Pharmabiz

Hotspots & growth opportunities in biomanufacturing

THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.

time to read

3 mins

November 27, 2025

Chronicle Pharmabiz

Omega Hospitals acquires Cytecare Hospitals

Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.

time to read

2 mins

November 27, 2025

Chronicle Pharmabiz

Devices sector hails withdrawal of QCOs

THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.

time to read

1 min

November 27, 2025

Chronicle Pharmabiz

'There is urgent need for tech-focused regulatory approach for med devices'

THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.

time to read

2 mins

November 27, 2025

Listen

Translate

Share

-
+

Change font size